Farrell Simon
Chief Commercial Officer, Trevi Therapeutics, Inc.
Companies
- Serina Therapeutics, Inc.Board member Jul 23, 2026 to now1
- Trevi Therapeutics, Inc.Chief Commercial Officer Feb 16, 2023 to now2
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Trevi Therapeutics, Inc. TRVI76,900 shares3$917.0K at $11.93Mar 10, 2025
As of each latest filing. The line shows shares held over time.
Recent filings
- Mar 10, 2025Sold 4,350 shares at $7.15 of Trevi Therapeutics, Inc.3
- Mar 10, 2025Sold 76,963 shares at $6.73 of Trevi Therapeutics, Inc.3
- Mar 10, 2025Exercised options 31,250 shares at $0.51 of Trevi Therapeutics, Inc.3
- Mar 10, 2025Exercised options 63,813 shares at $3.91 of Trevi Therapeutics, Inc.3
- Mar 10, 2025Exercised options 17,500 shares at $3.21 of Trevi Therapeutics, Inc.3
- Jun 20, 2023Exercised options 6,250 shares at $0.51 of Trevi Therapeutics, Inc.4
- Mar 7, 2023Exercised options 18,750 shares at $0.51 of Trevi Therapeutics, Inc.5
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4SEC EDGARForm 4 filed Jun 21, 2023
- 5SEC EDGARForm 4 filed Mar 8, 2023